Aepeli

“What does this AI touch when it’s wrong?”

We keep seeing healthcare boards move past “build a policy” and ask a sharper question: can we trace one AI output all the way to its downstream consequences?

Instead of a fuzzy governance bucket, we map a single loop:

1) user prompt

2) clinical decision support output

3) documentation artifact (note, order, pathway)

4) downstream billing and denial outcomes

Here’s why this matters right now: OpenAI’s January 2026 “AI as a Healthcare Ally” report estimates 5%+ of ChatGPT messages are health-focused, and about 70% of those health questions happen after hours, when wrong guidance tends to propagate the furthest.

If your model can’t be followed end-to-end, what are you actually governing?

Your passion fades the minute growth becomes guesswork.

We’ve seen it happen in boardrooms and revenue reviews: the team ships faster, the model changes quietly, and no one can answer the simplest question.
“Why did revenue move?”

When AI touches pricing, lead scoring, underwriting, or customer eligibility, that’s not a vibe issue. It’s governance.

Define one board-ready control that protects your revenue model:
1) An audit trail that ties outputs to decisions and versions

2) Bias monitoring with clear thresholds and escalation paths

3) A Data Protection Impact Assessment trigger when your AI is high-risk

Enterprise buyers and regulators increasingly expect EU AI Act readiness before enforcement milestones.

If you had to show this in 10 minutes, what would you use as your single source of truth?

Your AI governance video is doing the one thing that kills conversions: it sounds like thought leadership.

Part 1 (board-level question):
Can we explain AI impact on revenue and risk?

Part 2 (one technical evidence point):
What can we show, not just claim, from our audit trail or monitoring signals?

Part 3 (micro-commitment):
Reply “AUDIT” and we will send the 1-page model risk evidence checklist.

If your buyers cannot answer the board question in plain language, and cannot point to the evidence in under a minute, what do you think they will assume about your governance?

Boards are asking about AI… then they panic when every answer needs a person.

NACD’s 2025 survey puts the tension in numbers: 62% of boards discuss AI, but only 27% have formally added AI governance.

We’ve seen the failure mode. Teams say “human-in-the-loop” and then wire it like a universal approval queue. Latency climbs. Output volume drops. Oversight becomes a bottleneck.

Here’s the architecture we board-report instead:

1) Define decision tiers

Auto: run as designed
Auto-approve: safe range, logged
Human review: exceptions only

2) Log every override

Capture: what changed, why it was reviewed, what rule triggered the escalation

3) Route by exception rules, not by volume

Only the cases that matter to safety, revenue impact, or policy risk reach humans

If your workflow can’t explain overrides in plain language, what will your board ask for next?

Aepeli